Navigation Links
Nile Therapeutics to Collaborate with Medtronic on Clinical Development of Cenderitide for Heart Failure and Renal Disease
Date:2/28/2011

statements regarding the timing, progress and anticipated results of the clinical development, regulatory processes, clinical trial timelines, expected patient enrollment, anticipated benefits of cenderitide, Nile's strategy, future operations, outlook, milestones, the timing and success of Nile's product development, future financial position, future financial results, plans and objectives of management are forward-looking statements. Nile may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on Nile's forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements Nile makes. Various important factors that could cause actual results or events to differ materially from the forward-looking statements that Nile makes include Nile's need to raise additional capital to fund its product development programs to completion, Nile's reliance on third-party researchers to develop its product candidates, and its lack of experience in developing and commercializing pharmaceutical products. Additional risks are described in greater detail in the reports Nile files with Securities and Exchange Commission, including those described under the caption "Risk Factors" in Item 1A of its Annual Report on Form 10-K for the year ended December 31, 2009 filed with the Securities and Exchange Commission on March 3, 2010. Nile is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.


'/>"/>
SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action
2. Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
3. Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call
4. Echo Therapeutics Reports Symphony™ tCGM System Ahead of Schedule
5. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
6. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference
7. Echo Therapeutics Announces Appointments to Board of Directors
8. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
9. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16
10. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
11. Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal™ Co-administered with Enzyme Replacement Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/rt3mhz/deciphering ... "Deciphering Global Major Pharmaceutical Companies, New Outsourcing Demands ... It has been publicly recognized that global ... series of challenges in the recent years. The ... in small molecule product manufacturing; increasingly challenging process ...
(Date:7/7/2015)... 7, 2015   Decision Resources Group ... dialysis patient management in the U.S. versus the ... U.S. and EU5 nephrologists from approximately 1,870 dialysis ... the most commonly used renal medications in dialysis ... considerably between the two regions.      Other ...
(Date:7/7/2015)... BANGALORE , July 7, 2015 ... innovative clinical trial data management solutions, has been featured ... publication named " EDC and eCOA / ePRO Market ... is one of the leading providers of research and ... 22 EDC and eCOA / ePRO tools in the ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... Minimally Invasive Surgery Symposium (MISS) will include discussion of ... surgery, single-port bariatric surgery, transoral gastroplasty, and other "frontier" ... by MISS Executive Director Philip R Schauer, MD, on ... , The five-day CME conference, which will be held ...
... Oct. 27 Endologix, Inc. (Nasdaq: ... disorders, today announced financial results for the three and ... McDermott, Endologix President and Chief Executive Officer, said, "Our ... sales of new products by our domestic sales force ...
Cached Medicine Technology:Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 2Endologix Reports 47% Third Quarter 2009 Revenue Growth 2Endologix Reports 47% Third Quarter 2009 Revenue Growth 3Endologix Reports 47% Third Quarter 2009 Revenue Growth 4Endologix Reports 47% Third Quarter 2009 Revenue Growth 5Endologix Reports 47% Third Quarter 2009 Revenue Growth 6Endologix Reports 47% Third Quarter 2009 Revenue Growth 7Endologix Reports 47% Third Quarter 2009 Revenue Growth 8
(Date:7/7/2015)... ... July 07, 2015 , ... ... provider of advanced delivery technologies and development solutions for drugs, biologics and ... agreement with Excelimmune, Inc. to access its antibody combination therapy (ACT) technology ...
(Date:7/7/2015)... CA (PRWEB) , ... July 07, 2015 , ... Safe ... tests every single fish for mercury. Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts ... canned tuna. , “We developed the technology to test every fish for mercury,” said ...
(Date:7/7/2015)... ... 07, 2015 , ... The Immune Deficiency Foundation (IDF) launched ... using its IDF ePHR, an electronic personal health record powered by Get Real ... track their health information, including symptoms, diagnoses, medications, infusions and other critical health ...
(Date:7/7/2015)... ... July 07, 2015 , ... On Saturday, May 16th, 2015, the ... Manistee Golf and Country Club. Best Drug Rehabilitation staff members were delighted to join ... underprivileged children. Kiwanis International, the parent of the Manistee Kiwanis Club, is a global ...
(Date:7/7/2015)... ... July 07, 2015 , ... On June 22nd-26th, 2015, ... of the National Baptist Convention 110th Annual Session of the National Baptist Congress ... collaboration of churches and their congregations, medical professionals and health-related organizations, this week ...
Breaking Medicine News(10 mins):Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3
... Jeff Getty, a sport in the true sense of the ... famous bone marrow transplant from a baboon//, passed away in ... and companion for 26 years, his dad and three siblings. ... Calif. Getty following a cancer treatment. He became famous after ...
... slowed by NHS hospitals because they are serving meals that ... of catering at 97 health trusts. ,The survey ... by food brought in by relatives and friends. Over 37% ... smelled or tasted disgusting. ,Over a fifth of patients claimed ...
... have reiterated that knocking off a few pounds and ... arthritis//. Doctors found nearly 31% of the obese suffered ... only 16% of arthritis sufferers from the normal weight ... Control have communicated the results conducted from national surveys ...
... minister of Australia, stirred up the hearts of many when ... time that she had battled cancer almost ten years ... Centre, she was addressing an august gathering of over 800 ... cancer report.,Over the ‘Pink Ribbon’ breakfast meeting at Sydney this ...
... of an 11-year-old boy yesterday of H5N1 bird flu infection. ... in Indonesia to 53 and cases of infection, 71. ... was reported to have had contact with infected birds. He ... Thursday, and died Saturday evening. ,In Indonesia backyard poultry ...
... Montana has revealed that methamphetamine, when administered in rats and ... used initially to aggravate stroke symptoms and study its toxicity ... in further attempts. ,The research was done on thin ... for learning functions. They were kept in culture for nine ...
Cached Medicine News:Health News:NHS Food Slowing Patient Recovery 2
...
Designed to minimize emblolic debris in SVGs and carotids...
... the ability of interventional cardiologists and ... disease, and provides non-interventional cardiologists with ... treatment of patients who have become ... provides a noninvasive, atraumatic treatment for ...
... petite titanium model comes with ... lumen) and is our smallest ... offer larger lumen equivalency while ... lumen offset-tip catheters are available ...
Medicine Products: